Cargando…
Association of Voltage-Gated Sodium Channel Genetic Polymorphisms with Oxaliplatin-Induced Chronic Peripheral Neuropathy in South Indian Cancer Patients
Oxaliplatin is a platinum drug active against digestive tract cancers. Among its side effects, peripheral neuropathy is one of the dose-limiting toxicities. This affects around 50 to 70% of patients but the pathophysiology of development of oxaliplatin-induced peripheral neuropathy (OXAIPN) remains...
Autores principales: | Palugulla, Sreenivasulu, Thakkar, Dimpal N, Kayal, Smita, Narayan, Sunil K, Dkhar, Steven Aibor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773806/ https://www.ncbi.nlm.nih.gov/pubmed/29172294 http://dx.doi.org/10.22034/APJCP.2017.18.11.3157 |
Ejemplares similares
-
Oxaliplatin-induced Peripheral Neuropathy in South Indian Cancer Patients: A Prospective Study in Digestive Tract Cancer Patients
por: Palugulla, Sreenivasulu, et al.
Publicado: (2017) -
A Polymorphism Located Near PMAIP1/Noxa Gene Influences Susceptibility to Hodgkin Lymphoma Development in South India
por: Thakkar, Dimpal N, et al.
Publicado: (2017) -
Voltage-gated sodium channels in diabetic sensory neuropathy: Function, modulation, and therapeutic potential
por: Bigsby, Stephanie, et al.
Publicado: (2022) -
Fenestropathy of Voltage-Gated Sodium Channels
por: Gamal El-Din, Tamer M., et al.
Publicado: (2022) -
Voltage-gated sodium channels assemble and gate as dimers
por: Clatot, Jérôme, et al.
Publicado: (2017)